Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer-Reference-Cited by-同舟云学术

Period circadian regulator 2 suppresses drug resistance to cisplatin by PI3K/AKT pathway and improves chronochemotherapeutic efficacy in cervical cancer

Published:2022-01 Issue: Volume:809 Page:146003
ISSN:0378-1119
Container-title:Gene
language:en
Short-container-title:Gene

Author:

Wang Zhaoxia^ORCID,Li Fengyan,He Simin,Zhao Le,Wang Fuyuan

Publisher

Elsevier BV

Subject

Genetics,General Medicine

Reference32 articles.

1. KMT2D Deficiency Impairs Super-Enhancers to Confer a Glycolytic Vulnerability in Lung Cancer;Alam;Cancer Cell,2020

2. Per2 participates in AKT-mediated drug resistance in A549/DDP lung adenocarcinoma cells;Chen;Oncol Lett,2017

3. Du, B. and Shim, J.S. 2016. Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer. Molecules. 21.

4. Low GAS5 expression may predict poor survival and cisplatin resistance in cervical cancer;Fang;Cell Death Dis,2020

5. SOX9/miR-130a/CTR1 axis modulates DDP-resistance of cervical cancer cell;Feng;Cell Cycle,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biological clock regulation by the PER gene family: a new perspective on tumor development;Frontiers in Cell and Developmental Biology;2024-05-15

2. m6A Methyltransferase KIAA1429 Regulates the Cisplatin Sensitivity of Gastric Cancer Cells via Stabilizing FOXM1 mRNA;Cancers;2022-10-14

3. The Relevance of Circadian Clocks to Stem Cell Differentiation and Cancer Progression;NeuroSci;2022-03-29

4. The circadian clock and cancer: links between circadian disruption and disease Pathology;The Journal of Biochemistry;2022-02-22

5. Protein tyrosine phosphatase receptor type Z1 inhibits the cisplatin resistance of ovarian cancer by regulating PI3K/AKT/mTOR signal pathway;Bioengineered;2022-01-01